Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 790
Gene Symbol: CAD
CAD 		0.020 Biomarker group BEFREE • With CAD, sensitivity increases in patients with prostate tumours ≥10 mm and/or GS > 6. 28386721 2017
Entrez Id: 367
Gene Symbol: AR
AR 		0.600 Biomarker group LHGDN [The androgen receptor: molecular pathology]. 12465595 2002
Entrez Id: 5728
Gene Symbol: PTEN
PTEN 		0.600 Biomarker group LHGDN [Role of PTEN protein in multidrug resistance of prostate cancer cells]. 18702307 2008
Entrez Id: 2475
Gene Symbol: MTOR
MTOR 		0.050 Biomarker group LHGDN [Role of PTEN protein in multidrug resistance of prostate cancer cells]. 18702307 2008
Entrez Id: 9429
Gene Symbol: ABCG2
ABCG2 		0.020 Biomarker group LHGDN [Role of PTEN protein in multidrug resistance of prostate cancer cells]. 18702307 2008
Entrez Id: 4363
Gene Symbol: ABCC1
ABCC1 		0.010 Biomarker group LHGDN [Role of PTEN protein in multidrug resistance of prostate cancer cells]. 18702307 2008
Entrez Id: 3690
Gene Symbol: ITGB3
ITGB3 		0.360 Biomarker group CTD_human [Prognostic implications of GP3a glucoprotein gene PLA1/PLA2 allele in prostatic cancer: pilot results of the study]. 16158739 2005
Entrez Id: 1113
Gene Symbol: CHGA
CHGA 		0.050 AlteredExpression group LHGDN [Plasma chromogranin-A (CgA)--a potential marker for diagnosis, monitoring and management of prostate cancer patients]. 16450720 2006
Entrez Id: 2100
Gene Symbol: ESR2
ESR2 		0.400 Therapeutic group CTD_human [Implications of estrogens and their receptors for the development and progression of prostate cancer]. 16220300 2005
Entrez Id: 2100
Gene Symbol: ESR2
ESR2 		0.400 Biomarker group CTD_human [Implications of estrogens and their receptors for the development and progression of prostate cancer]. 16220300 2005
Entrez Id: 2099
Gene Symbol: ESR1
ESR1 		0.380 Biomarker group CTD_human [Implications of estrogens and their receptors for the development and progression of prostate cancer]. 16220300 2005
Entrez Id: 23600
Gene Symbol: AMACR
AMACR 		0.400 Biomarker group LHGDN [Evaluation of p63 and p504s markers for the diagnosis of prostate cancer]. 19068396 2008
Entrez Id: 8626
Gene Symbol: TP63
TP63 		0.220 Biomarker group LHGDN [Evaluation of p63 and p504s markers for the diagnosis of prostate cancer]. 19068396 2008
Entrez Id: 6715
Gene Symbol: SRD5A1
SRD5A1 		0.540 Biomarker group CTD_human [Dutasteride in the treatment of hormone refractory prostate cancer]. 18500220 2008
Entrez Id: 6716
Gene Symbol: SRD5A2
SRD5A2 		0.400 Biomarker group CTD_human [Dutasteride in the treatment of hormone refractory prostate cancer]. 18500220 2008
Entrez Id: 1586
Gene Symbol: CYP17A1
CYP17A1 		0.350 GeneticVariation group LHGDN [Association between the polymorphism of CYP17 gene and risk of prostate cancer in chinese vigurs men]. 16519145 2006
Entrez Id: 51341
Gene Symbol: ZBTB7A
ZBTB7A 		0.300 Therapeutic group CTD_human Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion. 23727861 2013
Entrez Id: 206358
Gene Symbol: SLC36A1
SLC36A1 		0.010 AlteredExpression group BEFREE XMRV provirus integration sites were mapped in DNA isolated from human prostate tumor tissue to genes for two transcription factors (NFATc3 and CREB5) and to a gene encoding a suppressor of androgen receptor transactivation (APPBP2/PAT1/ARA67). 17234809 2007
Entrez Id: 10513
Gene Symbol: APPBP2
APPBP2 		0.010 AlteredExpression group BEFREE XMRV provirus integration sites were mapped in DNA isolated from human prostate tumor tissue to genes for two transcription factors (NFATc3 and CREB5) and to a gene encoding a suppressor of androgen receptor transactivation (APPBP2/PAT1/ARA67). 17234809 2007
Entrez Id: 367
Gene Symbol: AR
AR 		0.600 GeneticVariation group BEFREE XMRV provirus integration sites were mapped in DNA isolated from human prostate tumor tissue to genes for two transcription factors (NFATc3 and CREB5) and to a gene encoding a suppressor of androgen receptor transactivation (APPBP2/PAT1/ARA67). 17234809 2007
Entrez Id: 9586
Gene Symbol: CREB5
CREB5 		0.010 AlteredExpression group BEFREE XMRV provirus integration sites were mapped in DNA isolated from human prostate tumor tissue to genes for two transcription factors (NFATc3 and CREB5) and to a gene encoding a suppressor of androgen receptor transactivation (APPBP2/PAT1/ARA67). 17234809 2007
Entrez Id: 4775
Gene Symbol: NFATC3
NFATC3 		0.010 AlteredExpression group BEFREE XMRV provirus integration sites were mapped in DNA isolated from human prostate tumor tissue to genes for two transcription factors (NFATc3 and CREB5) and to a gene encoding a suppressor of androgen receptor transactivation (APPBP2/PAT1/ARA67). 17234809 2007
Entrez Id: 1191
Gene Symbol: CLU
CLU 		0.400 AlteredExpression group BEFREE Xenografts derived from a human prostate tumor cell line (PC-3) regressed following treatment with MDL 101,731 and the relative levels of TRPM-2 mRNA increased up to threefold in drug-treated animals. 8549673 1996
Entrez Id: 7226
Gene Symbol: TRPM2
TRPM2 		0.010 AlteredExpression group BEFREE Xenografts derived from a human prostate tumor cell line (PC-3) regressed following treatment with MDL 101,731 and the relative levels of TRPM-2 mRNA increased up to threefold in drug-treated animals. 8549673 1996
Entrez Id: 5444
Gene Symbol: PON1
PON1 		0.320 Biomarker group CTD_human Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer. 21716162 2011